Normal breast (n = 3) and breast carcinoma (n = 61) samples were analyzed on cDNA microarrays. Sample data includes tumor percentage, age, E-Cadherin status, estrogen receptor status, grade, HER2 status, lymph node metastasis status, and progesterone receptor status. Here, ERBB2 is linked to neoplasm.